专题:Coagulation, Bradykinin, Polyphosphates, and Angioedema

This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology.
最新文献
Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series

article Full Text OpenAlex

Pyridostigmine and IVIG-Induced Coronary Vasospasm in Myasthenia Gravis: A Rarely Reported Side Effect of Treatment of MG

article Full Text OpenAlex

Determining the most frequent combinations of drugs prescribed prior to bullous pemphigoid diagnosis using association rule mining: a UK population-based case-control study

article Full Text OpenAlex

The Role of PTEN Tumor Suppressor Genes in Endometrial Cancer

article Full Text OpenAlex

Recurrent C3 Glomerulonephritis (C3GN) in Kidney Transplant Recipients: A Case Highlighting the Role of Iptacopan

article Full Text OpenAlex

Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025

review Full Text OpenAlex

Evaluating the usefulness of C5 and C5AR1 as genetic biomarkers of IgA-mediated vasculitis

article Full Text OpenAlex

Characterization of Novel Splicing Mutations and a Recurrent Deletion in COLQ Congenital Myasthenic Syndrome

article Full Text OpenAlex

Wnt/β-catenin signaling pathway role in the endometriosis pathogenesis

article Full Text OpenAlex

Therapeutic Role of Venous Leg Compression in Worsening Heart Failure With Predominant Extravascular Congestion: A Case Report

article Full Text OpenAlex

近5年高被引文献
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

article Full Text OpenAlex 867 FWCI146.529

Avacopan for the Treatment of ANCA-Associated Vasculitis

article Full Text OpenAlex 755 FWCI104.627

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

review Full Text OpenAlex 490 FWCI18.618

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update

article Full Text OpenAlex 344 FWCI73.248

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

article Full Text OpenAlex 307 FWCI24.915

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 268 FWCI25.086

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

article Full Text OpenAlex 260 FWCI55.685

Therapeutic options in VEXAS syndrome: insights from a retrospective series

review Full Text OpenAlex 246 FWCI10.405

Abelacimab for Prevention of Venous Thromboembolism

article Full Text OpenAlex 242 FWCI35.154

Milvexian for the Prevention of Venous Thromboembolism

article Full Text OpenAlex 211 FWCI30.803